Bioventix PLC (LON:BVXP – Get Rating) shares crossed above its fifty day moving average during trading on Monday . The stock has a fifty day moving average of GBX 4,033.13 ($48.50) and traded as high as GBX 4,100 ($49.30). Bioventix shares last traded at GBX 3,990 ($47.98), with a volume of 2,202 shares.
Bioventix Stock Performance
The stock has a market cap of £201.49 million, a price-to-earnings ratio of 2,732.88 and a beta of 0.41. The company has a 50 day moving average of GBX 4,033.13 and a 200-day moving average of GBX 3,662.01.
Insider Buying and Selling at Bioventix
In other Bioventix news, insider Peter John Harrison sold 57,558 shares of the stock in a transaction dated Tuesday, January 31st. The stock was sold at an average price of GBX 3,750 ($45.09), for a total value of £2,158,425 ($2,595,508.66). 10.15% of the stock is owned by corporate insiders.
About Bioventix
Bioventix PLC creates, manufactures, and supplies sheep monoclonal antibodies (SMAs) for diagnostic applications worldwide. The company offers a portfolio of purified SMAs for thyroid, vitamin D, cardiac, drugs of abuse, fertility, oncology, and miscellaneous indications. It also provides contract SMAs and recombinant services.
Featured Stories
- Go Where the Money Is. Here’s 3 Top Bank Dividend Stocks to Buy
- Another Catalyst For Mullen Automotive Stock
- Solar Tech-Services; Nextracker Should Be On Your Radar
- Is American Lithium a Safe Bet as Demand for Lithium Soars
- Highwoods Properties, High-quality Real Estate for a Discount
Receive News & Ratings for Bioventix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bioventix and related companies with MarketBeat.com's FREE daily email newsletter.